MoonLake Immunotherapeutics - CLASS A ORD (MLTX)

Historical Portfolio Holders from Q1 2022 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / CLASS A ORD
Shares, excl. options Q2 2024
60.6M
Holdings value Q2 2024
$2.67B
Value change Q2 2024
+$45.5M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
108
Number of buys Q2 2024
9
Number of sells Q2 2024
-2
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 692K $34.7M +$10.2M $50.42 9
2024 Q2 60.6M $2.67B +$45.5M $43.97 110
2024 Q1 59.3M $2.98B +$713K $50.23 116
2023 Q4 58.3M $3.52B +$159M $60.39 129
2023 Q3 56.3M $3.21B +$46.6M $57.00 119
2023 Q2 56.1M $2.86B +$861M $51.00 82
2023 Q1 39.4M $843M +$59.2M $21.39 43
2022 Q4 37.7M $396M +$8.23M $10.50 32
2022 Q3 36.9M $291M +$3.12M $7.76 24
2022 Q2 36.5M $190M +$183M $5.25 22
2022 Q1 654K $7.26M +$7.26M $11.10 1